Searched for
GENNOVA BIOPHARMACEUTICALS
Drug panel may review Gennova's mRNA Omicron booster vaccinePune-based Gennova Biopharmaceuticals had submitted data to the drug regulator this month, amid an increase in the number of Covid-19 cases...18 Apr, 2023, 12.33 AM IST- Gemcovac-19: India's first mRNA jab may soon join vaccine driveGennova Biopharmaceuticals submitted the data in the month of April followed by additional data in the month of May. Earlier last month, in...14 Jul, 2022, 12.13 AM IST
- Panel recommends emergency use nod to India's 1st mRNA vaccineThe Subject Expert Committee recommended the authorisation in a meeting held on Friday. The vaccine is developed by Pune-based Gennova Biop...29 Jun, 2022, 12.56 AM IST
- DCGI approves indigenous mRNA Covid jab for emergency use in 18 yrs & aboveAbout 70 lakh doses of the vaccine have already been cleared by the government’s nodal Central Drug Laboratory (CDL) at Kasauli and it is e...29 Jun, 2022, 12.09 AM IST
- Gennova's mRNA-based vaccine to be delayedGennova had last month submitted interim data on India's first indigenously developed mRNA Covid vaccine to the drug regulator. The Central...02 Apr, 2022, 12.36 AM IST
- Gennova Biopharma submits final vaccine trial data to regulatorPune-based Gennova is developing the country's first indigenously developed mRNA vaccine for Covid-19. The subject expert committee under t...12 Mar, 2022, 01.01 AM IST
- Gennova Biopharmaceuticals developing Omicron specific vaccineGennova Biopharmaceuticals, a subsidiary of Pune-based drugmaker Emcure Pharmaceuticals, is developing a Covid-19 vaccine on its mRNA platf...12 Feb, 2022, 10.18 AM IST
- Pune-based Gennova to use SII's Covishield vaccine as the comparatorTo assess the immunogenicity of the mRNA vaccine, Gennova will have to use Covishield — an existing vaccine — as a comparator, as the regul...02 Sep, 2021, 08.09 AM IST
- Gennova Biopharma's COVID-19 vaccine found to be safe in early trialsThe company has been allowed to conduct further studies to test efficacy and other parameters.24 Aug, 2021, 04.24 PM IST
- Experts likely to drop placebo arm from trials in policy shiftExperts are discussing whether administering a placebo to volunteers in a clinical trial is necessary in order to assess the safety and eff...04 Aug, 2021, 07.02 AM IST
- HGCO19 vaccine candidate: Gennova starts enrolment for Phase 1/2 human clinical trialsThe DBT said it has approved additional funding towards clinical studies of India's first of its kind' mRNA-based COVID-19 vaccine, HGCO19,...13 Apr, 2021, 01.20 PM IST
- Gennova Biopharmaceuticals granted conditional permission for human clinical trial of its COVID-19 vaccineThe recommendations of the Subject Expert Committee (SEC) on COVID-19, which deliberated upon the proposal submitted by the firm for grant ...09 Dec, 2020, 10.44 PM IST
- COVID-19: Prime Minister Modi to visit Serum Institute of India in Pune on November 28Prime Minister Narendra Modi will on Saturday visit the Pune-based Serum Institute of India, which has partnered with global pharma giant A...26 Nov, 2020, 10.21 PM IST
- Gennova moves application to dismiss Boehringer’s case on stroke medicineGennova alleges that Boehringer did not disclose a PIL still pending with another bench at the court on the same objections when it filed i...05 Sep, 2016, 05.25 PM IST
- Battle over stroke medicine between Boehringer and Gennova heats up at courtGennova didn’t follow the ethical guidelines issued by the Indian Council of Medical Research (ICMR) while designing its clinical study for...31 Aug, 2016, 11.02 PM IST
- Delhi High Court defers order blocking Gennova’s stroke drugGennova's drug can't be approved as a biosimilar of tenecteplase as the original drug isn't prescribed for strokes, argued P Chidambaram, c...25 Aug, 2016, 08.36 PM IST
- Action between Boehringer Ingelheim and Gennova over stroke medicine moves to courtThe approval of tenectaplase for use in stroke patients has been a point of contention between German drug maker Boehringer Ingelheim and G...24 Aug, 2016, 09.07 AM IST
Load More
